Longitudinal analysis of treatment-induced genomic alterations in gliomas

BACKGROUND: Glioblastoma multiforme (GBM) constitutes nearly half of all malignant brain tumors and has a median survival of 15 months. The standard treatment for these lesions includes maximal resection, radiotherapy, and chemotherapy; however, individual tumors display immense variability in their...

Descripción completa

Detalles Bibliográficos
Autores principales: Erson-Omay, E. Zeynep, Henegariu, Octavian, Omay, S. Bülent, Harmancı, Akdes Serin, Youngblood, Mark W., Mishra-Gorur, Ketu, Li, Jie, Özduman, Koray, Carrión-Grant, Geneive, Clark, Victoria E., Çağlar, Caner, Bakırcıoğlu, Mehmet, Pamir, M. Necmettin, Tabar, Viviane, Vortmeyer, Alexander O., Bilguvar, Kaya, Yasuno, Katsuhito, DeAngelis, Lisa M., Baehring, Joachim M., Moliterno, Jennifer, Günel, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290635/
https://www.ncbi.nlm.nih.gov/pubmed/28153049
http://dx.doi.org/10.1186/s13073-017-0401-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290635/
https://www.ncbi.nlm.nih.gov/pubmed/28153049
http://dx.doi.org/10.1186/s13073-017-0401-9

Ejemplares similares